Caroline Farah Lembck, MBA, PhD (abd)

• System Integration and Custom Software Development Design, development, customization, deployment and support of enterprise-driven custom software applications and solutions, e-business (B2B) and e-commerce (B2C) solutions, e-government (G2G, G2B and G2C) and e-health solutions • Technology Provision and IT Consulting Combining emerging technologies (like Cloud Computing, Software-as-a-Service, Social Networks, Mobility, Semantic Web, Linked Open Data, and Big Data Management) in order to help organizations to meet their business strategy goals and benefit from the power of technology innovation Definition of the IT Strategy, Infrastructure and Enterprise Architecture required for organizations and enterprises to support the efficient and effective achievement of their business objectives

DatChat Inc. is a secure messaging, metaverse, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. The DatChat Messenger & Private Social Network presents technology that allows users to change how long their messages can be viewed before or after users send them, prevents screenshots, and hides encrypted photos in plain sight on camera rolls. DatChats patented technology offers users a traditional texting experience while providing control and security for their messages. With the DatChat Messenger, a user can decide how long their messages last on a recipients device, while feeling secure that at any time, they can delete individual messages or entire message threads, making it like the conversation never happened.

We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B™, which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy adult donors. We believe that by using the same cells that promote tissue repair, organ maintenance, and immune system function, we can develop safe and effective therapies for some of the most difficult diseases and conditions associated with aging. We are currently conducting Phase 1 and 2 clinical trials in the following indications: Aging Frailty, Alzheimer’s disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS), which is the current exception to our focus on aging. Our mission is to advance Lomecel-B™ and other cell-based product candidates into pivotal Phase 3 trials, with the goal of achieving regulatory approvals, subsequent commercialization and broad use by the healthcare community. Our philosophy is that healthy aging can be improved through regenerative medicine approaches. Life expectancy has substantially increased over the past century as a result of medical and public health advancements. However, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging – a period known as healthspan. As we age, we experience a profound decline, in both number and function, in our own MSCs, a decrease in immune system function, decline in blood vessel functioning, chronic inflammation and other issues. Our clinical data suggest that Lomecel-B™ addresses these conditions through multiple mechanisms of action, or MOAs, that simultaneously target key aging-related processes.

Vinco Ventures (Nasdaq: BBIG) is focused on the development of digital media and content technologies. Vinco Ventures’ consolidated subsidiary, ZVV Media Partners, LLC, a joint venture of Vinco Ventures and ZASH Global Media and Entertainment Corporation, has an 80% ownership interest in Lomotif Private Limited. Vinco Ventures has a 100% ownership interest in AdRizer, LLC. For more information, please visit investors.vincoventures.com.

NextPlat is a global e-commerce platform company created to capitalize on multiple high-growth sectors and markets including technology and healthcare. Through acquisitions, joint ventures and collaborations, the Company intends to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-commerce presence and revenue. NextPlat currently operates an e-commerce communications division offering voice, data, tracking, and IoT products and services worldwide and pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care Inc. (OTCQB: RXMD).

By leveraging our immunology expertise, HCW is developing proprietary immunotherapy candidates to address chronic inflammation through inflammasome modulation and senescent cell clearance.

At Xenon Pharmaceuticals (NASDAQ:XENE), we are committed to providing a brighter future for patients suffering from neurological disorders. Our employees are smart, passionate, dedicated, and driven by their incredibly important work to discover, develop, and deliver innovative medicines for patients in need. We are looking for great people who thrive in a respectful, collaborative, inclusive, and productive culture to join the Xenon team. We are advancing an exciting pipeline of neurology-focused therapies, with a focus on commercializing novel treatments for epilepsy. Building upon the positive results and compelling data from our XEN1101 Phase 2b “X-TOLE” study in adult patients with focal epilepsy, our XEN1101 Phase 3 program includes studies in adult patients with focal onset seizures and primary generalized tonic-clonic seizures. In addition, XEN1101 is being evaluated as a treatment for major depressive disorder in both a company-sponsored Phase 2 clinical trial, as well as an investigator-led proof-of-concept study. We are also proud of the leading-edge science coming out of our discovery labs, where many innovative, early-stage research programs are underway. In addition to these proprietary programs, our pipeline includes clinical-stage programs with valued collaborators. Backed by a strong balance sheet to support our growth plans, we continue to build a fully integrated, premier neuroscience company with strong discovery, clinical development, corporate, and commercial operations.

At ZIVO Bioscience, Inc., we are dedicated to the study, development and commercialization of natural nutritional compounds and bioactive molecules derived from our proprietary algal strains. These compounds and mixtures can be extraordinarily complex and dynamic in nature. In addition to exceptional nutritional qualities, our compounds exhibit properties that, properly applied, can yield significant results in supporting a healthy immune response and related metabolic functions, among other beneficial effects.

micromobility.com Inc., a disruptive leader in the micromobility sector, founded by Salvatore Palella in 2015, combines expertise in retail, shared services, and vehicle rentals to revolutionize urban transportation. With operations spanning across the US and Europe, the holding group encompasses shared micromobility solutions through Helbiz Inc., vehicle rentals via Wheels Labs Inc. and e-commerce and planned brick-and-mortar stores via the micromobility.com brand. Committed to providing eco-friendly, affordable solutions and enhancing global accessibility, micromobility.com Inc. sets the standard for professional excellence in the micromobility landscape. For more information, visit www.micromobility.com.

Thanks to years of experience in different development fields and to continuous growth of the know-how, our team manages to create quality and highly professional products, made often in mixed form with the interaction of different technologies and programming languages. Our company is leader in security information, in the development of applications for mobile devices, in enterprise systems consulting and training of developers and graphics with high professional profile. If you can imagine it, we can create it.

Virpax’s lead product candidate, Probudur, is being developed using our proprietary liposomal encapsulation to deliver a sustain release of local anesthetic at the wound/incision site to control post-operative pain for 96 hours. We have executed Cooperative Research and Development Agreements (CRADA), as well as the National Institute of Health/NCATS; U.S. Army Institute of Surgical Research/Department of Defense to develop differentiated non-addictive treatment options and the Epilepsy Therapy Screening Program (ETSP) which is focused on focused on addressing drug resistant epilepsy, disease prevention and modification. The three products in development are targeting unmet global needs in three separate multi-billion-dollar markets, including rare diseases. Our proprietary drug-delivery-platforms have been developed to optimize the efficacy of nonaddictive medications to manage Post Operative Pain, Severe Pain, Post Cancer Pain, PTSD, and Rare Pediatric Epilepsy including Lennox-Gastaut Syndrome (LGS) and Dravet Syndrome (Orphan Diseases)

Founded in 2018, Bakkt builds crypto technology that enables businesses to grow with the crypto economy. Through institutional-grade custody, trading, and onramp capabilities, our clients leverage technology that’s built for sustainable, long-term involvement in crypto.  With ways to activate crypto via SaaS or API, businesses can select the option thats best for their strategy.

Aerpio Pharmaceuticals is a pharmaceuticals company based out of 9987 Carver Road Suite 420, Cincinnati, Ohio, United States.

Clover Health (Nasdaq: CLOV) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare We aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. We do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. This strategy is underpinned by our proprietary software platform, the Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care. Making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. We offer affordable Medicare Advantage plans with extensive benefits, provide primary care physicians with the Clover Assistant, and also make comprehensive home-based care available via the Clover Home Care program. With our corporate headquarters in Nashville, Clover’s workforce is distributed around the U.S. and also includes a team of world-class technologists based in Hong Kong. We manage care for Medicare Advantage members in Alabama, Arizona, Georgia, Mississippi, New Jersey, Pennsylvania, South Carolina, Tennessee, and Texas. We are hiring software engineers, data scientists, designers and product folks who can help us understand our members’ wellness and steer them clear of any health risks down the road. If you’re a passionate person and interested in changing healthcare for the better, then Clover Health may just be the place for you.

Artelo Biosciences is a clinical stage company focused on modifying lipid-signaling pathways to improve treatments for people living with cancer (Nasdaq: ARTL)

(U.S. IFE Banking License Pending Approval: OCIF Application Submitted 04/2024) From the strategic vantage of Puerto Rico, LemVega International Bank, (“LVIB”), is a premier full-service private banking institution, adeptly uniting capitals across the Americas, Middle East, Asia, and Europe. We cater to high net worth individuals with a comprehensive array of services: from private banking to brokerage and dealing, asset management to investment strategy, and trust services to custodial solutions. Our expertise extends to crafting bespoke investment vehicles such as hedge funds, venture capital, and private equity, tailored to the unique aspirations of our clients. At LemVega, we’re more than a bank; we’re a multifaceted institution dedicated to managing, growing, and safeguarding wealth. Our commitment to excellence, innovation, and integrity ensures that every aspect of your financial journey is handled with the utmost sophistication. When a fund holds $1 million, it can only deploy exactly that amount, with earnings expected to compete with returns from equity markets and facing significant taxation. However, when that same $1 million is deposited in a bank like LemVega, it has the potential to support between $6 million and $8 million in loans. This increased capacity is due to the leveraging effect, where the cost of capital is determined by the interest rates on term deposits, greatly enhanced by Puerto Rico’s low 4% income tax rate.

VC + management firm accelerating AI, healthcare, fintech & deeptech startups with capital and strategic support.

LemXBio is a pre-clinical biotechnology company focusing on breakthrough therapies and advanced medicines for the future.

Welcome to Solid Rep ®, your trusted intellectual property law firm. Our mission is to protect, defend and ensure our clients unique presence in the marketplace. With our counsel, we empower our clients to make intelligent and informed decisions on current realities and future opportunities. At Solid Rep ®, we are driven by our vision to become the most sought-after legal service provider for business owners in the USA, Latino-americanos expanding their businesses to the USA, and everyone wishing to do business in Puerto Rico. Our goal is to offer our clients unparalleled legal support and to help them achieve their business objectives. With our team of experienced legal professionals, we provide comprehensive and customized solutions that cater to each clients unique needs. Our expertise covers trademark and copyright law, patent law, and intellectual property litigation. At Solid Rep ®, we are committed to building lasting relationships with our clients based on trust, respect, and a shared commitment to success. Contact us today to learn more about how we can help you protect your intellectual property and achieve your business goals.

Smart Global Holdings is now Penguin Solutions! Please follow our Penguin Solutions page for news and updates moving forward. At Penguin Solutions, we understand the boundless potential of technology and support our customers in turning cutting-edge ideas into outcomes—faster, and at any scale. With over two decades of experience as trusted advisors, Penguin Solutions is an end-to-end technology company solving the industry’s most complex challenges in computing, memory, and LED solutions. Penguin designs, builds, deploys, and manages high-performance, high-availability enterprise solutions, allowing customers to achieve their breakthrough innovations. Learn more about us at https://www.penguinsolutions.com.